Internal Medicine, Endocrinology, Diabetes, & Metabolism · Peabody, MA
NPI
1497751374
Since 2005
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
27 Centennial Dr
Peabody, MA, 01960
Phone (978) 531-7677
Groups this clinician bills Medicare through
Medicare paid, 2024
$153K
3,010 services
Medicare patients, 2024
758
Average age 76
Drug cost, 2024
$2.0M
4,004 prescriptions
Company payments, 2025
$181
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Helen Kaulbach was code 99214 (office e&m - established), 844 times for 526 patients. In total Helen Kaulbach billed 3,010 services in 34 codes, and Medicare paid $153K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-07-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 844 | 526 | $90.96 | $77K |
| 95251 Test - Miscellaneous | Office | 299 | 112 | $25.75 | $7,700 |
| 99215 Office E&M - Established | Office | 245 | 169 | $129.01 | $32K |
| 36415 Venipuncture Blood Collection | Office | 240 | 202 | $8.65 | $2,076 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 185 | 159 | $12.43 | $2,300 |
| 99213 Office E&M - Established | Office | 185 | 170 | $60.15 | $11K |
| 83036 Blood Count | Office | 178 | 141 | $9.52 | $1,695 |
| 84443 Clinical Chemistry | Office | 122 | 103 | $16.46 | $2,008 |
| 84439 Clinical Chemistry | Office | 117 | 99 | $8.84 | $1,034 |
| 80048 Clinical Chemistry | Office | 100 | 92 | $8.29 | $829 |
| 80061 Clinical Chemistry | Office | 68 | 68 | $13.12 | $892 |
| 84460 Clinical Chemistry | Office | 64 | 64 | $5.19 | $332 |
| 84450 Clinical Chemistry | Office | 64 | 64 | $5.08 | $325 |
| 82962 Clinical Chemistry | Office | 53 | 52 | $3.21 | $170 |
| 99443 Telephone Services | Office | 48 | 46 | $94.32 | $4,527 |
By year: 2022 $170K for 4,573 services; 2023 $179K for 4,723 services; 2024 $153K for 3,010 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 240 | 202 | $8.65 | $2,076 |
| 83036 Blood Count | 178 | 141 | $9.52 | $1,695 |
| 84443 Clinical Chemistry | 122 | 103 | $16.46 | $2,008 |
| 84439 Clinical Chemistry | 117 | 99 | $8.84 | $1,034 |
| 80048 Clinical Chemistry | 100 | 92 | $8.29 | $829 |
| 80061 Clinical Chemistry | 68 | 68 | $13.12 | $892 |
| 84460 Clinical Chemistry | 64 | 64 | $5.19 | $332 |
| 84450 Clinical Chemistry | 64 | 64 | $5.08 | $325 |
| 82962 Clinical Chemistry | 53 | 52 | $3.21 | $170 |
| 82310 Clinical Chemistry | 34 | 33 | $5.06 | $172 |
Medicare prescription drug claims, 2024
In 2024, the drug Helen Kaulbach prescribed most often to Medicare patients was Levothyroxine Sodium, with 964 prescriptions and refills. In total Helen Kaulbach wrote 4,004 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 964 | 2,795 | 274 | $7,842 |
| Metformin Hcl Generic | 426 | 1,184 | 127 | $2,582 |
| Ozempic Semaglutide | 253 | 485 | 81 | $459K |
| Synthroid Levothyroxine Sodium | 180 | 533 | 51 | $8,139 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 168 | 470 | 67 | $12K |
| Tresiba Flextouch U-200 Insulin Degludec | 145 | 289 | 41 | $185K |
| Xultophy 100-3.6 Insulin Degludec/Liraglutide | 134 | 291 | 44 | $352K |
| Alendronate Sodium Generic | 128 | 350 | 44 | $940 |
| Jardiance Empagliflozin | 121 | 263 | 32 | $145K |
| Levoxyl Levothyroxine Sodium | 108 | 322 | 32 | $5,198 |
| Farxiga Dapagliflozin Propanediol | 85 | 201 | 23 | $104K |
| Mounjaro Tirzepatide | 83 | 112 | 25 | $121K |
| Pioglitazone Hcl Generic | 55 | 163 | 20 | $927 |
| Soliqua 100-33 Insulin Glargine/Lixisenatide | 47 | 90 | 16 | $71K |
| Trulicity Dulaglutide | 44 | 95 | 17 | $93K |
Brand drugs: 1,991 claims; generic drugs: 1,758 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Helen Kaulbach $181 ($181 in general payments such as food, travel and fees) from 5 companies. The largest payer was Novo Nordisk Inc with $89.1.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.